v3.25.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 29, 2025
Net loss per share  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive:

 

   Three months
ended
   Three months
ended
 
   March 29, 2025   March 30, 2024 
Non-vested restricted common stock   6,317,670    3,076,520 

 

The shares of the Company’s common stock issuable upon the exercise of stock options that were excluded from the calculation of diluted net loss per share because their effect would have been antidilutive are as follows:

 

   Three months
ended
   Three months
ended
 
   March 29, 2025   March 30, 2024 
Stock options   591,366     
Total   591,366